Unknown

Dataset Information

0

Approach to the patient after relapse of hairy cell leukemia.


ABSTRACT: The current hairy cell leukemia (HCL) treatment is excellent, but evidence of cure with purine analogs cladribine and pentostatin, is lacking. Significant long-term immune suppression, particularly to CD4+ T-cells, and declining complete remission rates with each course, make the identification of new therapies an important goal. The anti-CD20 monoclonal antibody (Mab) rituximab displays significant activity, and, while causing prolonged normal B-cell depletion, spares T-cells. Recombinant immunotoxins, containing an Fv fragment of a Mab fused to truncated Pseudomonas exotoxin, have shown efficacy in HCL resistant to both purine analogs and rituximab. LMB-2 targets CD25 and can induce remission providing the HCL cells are CD25+. All HCL cells display CD22. Recombinant anti-CD22 immunotoxin BL22, targeting CD22, has shown significant efficacy in phase I and II testing, and avoids prolonged suppression of both normal B- and T-cells. An improved high-affinity version of BL22, termed HA22, is currently undergoing phase I testing.

SUBMITTER: Kreitman RJ 

PROVIDER: S-EPMC7433026 | biostudies-literature | 2009 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Approach to the patient after relapse of hairy cell leukemia.

Kreitman Robert J RJ   Fitzgerald David J P DJ   Pastan Ira I  

Leukemia & lymphoma 20091001


The current hairy cell leukemia (HCL) treatment is excellent, but evidence of cure with purine analogs cladribine and pentostatin, is lacking. Significant long-term immune suppression, particularly to CD4+ T-cells, and declining complete remission rates with each course, make the identification of new therapies an important goal. The anti-CD20 monoclonal antibody (Mab) rituximab displays significant activity, and, while causing prolonged normal B-cell depletion, spares T-cells. Recombinant immun  ...[more]

Similar Datasets

| S-EPMC6051354 | biostudies-literature
| S-EPMC8870214 | biostudies-literature
| S-EPMC5455681 | biostudies-literature
| S-EPMC9028144 | biostudies-literature
| S-EPMC4918239 | biostudies-literature
| S-EPMC3689585 | biostudies-literature
| S-EPMC2803689 | biostudies-literature
| S-EPMC9815161 | biostudies-literature
| S-EPMC7435069 | biostudies-literature
| S-EPMC6087717 | biostudies-literature